University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 11 of 35
Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
NCT05152927
PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED
NCT05142332
Social Media Intervention to Stop Nicotine and Cannabis Vaping Among Adolescents
NCT04707911
Contingency Management for Smoking Cessation
NCT04982952
Pilot Trial of the Nutrition-Supported Diabetes Education Program
NCT05067452
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
NCT05105100
Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)
NCT04542382
Missed Period Pill Study
NCT04940013
Does Eliminating Coffee Avoid Fibrillation?
NCT05121519
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis
NCT05158153
HypErthermia as an Additional Treatment for the Biology and Experience of Depression
NCT05041361
Brain Health Together: Development and Pilot Test
NCT06914947
Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination
NCT04893265
Deprescribing Tamsulosin in Older Men
NCT05415748
Research on Improving Sleep During Pregnancy
NCT05017974
Adapting a Web-Based Professional Development for Mexican School Mental Health Providers Delivering Evidence-Based Intervention for ADHD and ODD
NCT05425966
Single-Visit and Two-Visit Endodontic Treatments
NCT07354373
CT Guided CI Programming
NCT04506424
Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health
NCT05746169
The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study
NCT04818034
Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia
NCT05158179
Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older Adults
NCT05021172
Changing Health Through Food Support for Diabetes
NCT04959487
DISulfiram for COvid-19 (DISCO) Trial
NCT04485130
Mindfulness-Based Stress Reduction in Dementia Caregivers
NCT04977245
Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease
NCT03256539
Efficacy of the Nanodropper Device on Pupillary Dilation
NCT05274321
Trial of Bilateral Sagittal Split Osteotomy Induced Paresthesia Using Ultrasonic vs. Reciprocating Saw Instrumentation
NCT05205616
Teletherapy in Children Who Are Deaf and Hard of Hearing
NCT04928209
Norepinephrine vs Phenylephrine During General Anesthesia
NCT04789330
Sleep and Social Experiences Study 2
NCT05166590
Australian UCSF Concussion in Athletes
NCT05769296
Mind Your Pain: Validating a Mindful Interoceptive Exposure Task for Patients With Chronic Low Back Pain
NCT06186193
The Use of Venlafaxine in Reducing Pain in Primary Total Knee Replacement
NCT05023278
The OPENS Trial: Offering Women PrEP (Aim 1)
NCT04621760
The California Home Abortion by Telehealth (CHAT) Study
NCT04432792
Enhancing Cognitive Control Abilities Using Mobile Technology in a Senior Living Community
NCT04905849
N95 Reuse During COVID-19
NCT05148793
Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)
NCT04409873
Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer
NCT04190056
Opioid Approach Bias Modification
NCT04436926
Study of Attention and Memory Treatments for Cancer Survivors
NCT04870320
Antibiotic Resistance In Eye Surgeries
NCT04750655
Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population
NCT05187910
ObeSity and Jobs in SoCioeconomically Disadvantaged CommUnities: A Randomized CLinical Precision Public HealTh Intervention --The SCULPT-Job Study
NCT04709549
Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery
NCT04370509
Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer
NCT04697524
Feasibility of Gamma Transcranial Alternating Current Stimulation to Reduce Beta-amyloid Load and Improve Memory
NCT04646499
Enhancing Cognitive Control in Mild Cognitive Impairment Via Non-invasive Brain Stimulation
NCT04647032
Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH
NCT04449510
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.